nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Pentagastrin—BCHE—peripheral nervous system neoplasm	0.0138	1	CrCbGaD
Nafarelin—GNRHR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0068	0.395	CbGpPWpGaD
Nafarelin—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Nafarelin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Nafarelin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00129	CcSEcCtD
Nafarelin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00129	CcSEcCtD
Nafarelin—Constipation—Topotecan—peripheral nervous system neoplasm	0.00124	0.00128	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00127	CcSEcCtD
Nafarelin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Nafarelin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Nafarelin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00126	CcSEcCtD
Nafarelin—Rash maculo-papular—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Nafarelin—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Nafarelin—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.0012	0.0698	CbGpPWpGaD
Nafarelin—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00123	CcSEcCtD
Nafarelin—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00122	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00121	CcSEcCtD
Nafarelin—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00119	CcSEcCtD
Nafarelin—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Nafarelin—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Nafarelin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00115	0.00119	CcSEcCtD
Nafarelin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00118	CcSEcCtD
Nafarelin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00118	CcSEcCtD
Nafarelin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nafarelin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nafarelin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nafarelin—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Nafarelin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00113	0.00116	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00116	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00115	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00115	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00115	CcSEcCtD
Nafarelin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Nafarelin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00114	CcSEcCtD
Nafarelin—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00109	0.00113	CcSEcCtD
Nafarelin—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00112	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00108	0.0625	CbGpPWpGaD
Nafarelin—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Nafarelin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00111	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.0011	CcSEcCtD
Nafarelin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00106	0.00109	CcSEcCtD
Nafarelin—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00109	CcSEcCtD
Nafarelin—Oedema—Vincristine—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Nafarelin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00104	0.00107	CcSEcCtD
Nafarelin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00107	CcSEcCtD
Nafarelin—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00107	CcSEcCtD
Nafarelin—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nafarelin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nafarelin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nafarelin—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Nafarelin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00102	0.00106	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nafarelin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nafarelin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nafarelin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Nafarelin—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00101	0.00105	CcSEcCtD
Nafarelin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.001	0.00103	CcSEcCtD
Nafarelin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.001	0.00103	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000993	0.00102	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000992	0.00102	CcSEcCtD
Nafarelin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000991	0.00102	CcSEcCtD
Nafarelin—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000989	0.00102	CcSEcCtD
Nafarelin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000985	0.00102	CcSEcCtD
Nafarelin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000984	0.00102	CcSEcCtD
Nafarelin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000983	0.00101	CcSEcCtD
Nafarelin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.00101	CcSEcCtD
Nafarelin—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000977	0.00101	CcSEcCtD
Nafarelin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00097	0.001	CcSEcCtD
Nafarelin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00097	0.001	CcSEcCtD
Nafarelin—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000967	0.000998	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000958	0.000989	CcSEcCtD
Nafarelin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000957	0.000988	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000956	0.000986	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.000985	CcSEcCtD
Nafarelin—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000954	0.000984	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00095	0.000981	CcSEcCtD
Nafarelin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00095	0.00098	CcSEcCtD
Nafarelin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00095	0.00098	CcSEcCtD
Nafarelin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000949	0.000979	CcSEcCtD
Nafarelin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000946	0.000976	CcSEcCtD
Nafarelin—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000942	0.000972	CcSEcCtD
Nafarelin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000935	0.000965	CcSEcCtD
Nafarelin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000931	0.000961	CcSEcCtD
Nafarelin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000927	0.000957	CcSEcCtD
Nafarelin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000921	0.00095	CcSEcCtD
Nafarelin—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000918	0.000947	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000944	CcSEcCtD
Nafarelin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000913	0.000942	CcSEcCtD
Nafarelin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000913	0.000942	CcSEcCtD
Nafarelin—Rash—Topotecan—peripheral nervous system neoplasm	0.000913	0.000942	CcSEcCtD
Nafarelin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000912	0.000941	CcSEcCtD
Nafarelin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000912	0.000941	CcSEcCtD
Nafarelin—Headache—Topotecan—peripheral nervous system neoplasm	0.000907	0.000936	CcSEcCtD
Nafarelin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.000934	CcSEcCtD
Nafarelin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000906	0.000934	CcSEcCtD
Nafarelin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000905	0.000934	CcSEcCtD
Nafarelin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000905	0.000934	CcSEcCtD
Nafarelin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000902	0.000931	CcSEcCtD
Nafarelin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000901	0.00093	CcSEcCtD
Nafarelin—Headache—Tretinoin—peripheral nervous system neoplasm	0.0009	0.000928	CcSEcCtD
Nafarelin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0009	0.000928	CcSEcCtD
Nafarelin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000897	0.000926	CcSEcCtD
Nafarelin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000897	0.000925	CcSEcCtD
Nafarelin—Rash—Melphalan—peripheral nervous system neoplasm	0.000894	0.000922	CcSEcCtD
Nafarelin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000893	0.000922	CcSEcCtD
Nafarelin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000888	0.000917	CcSEcCtD
Nafarelin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000886	0.000915	CcSEcCtD
Nafarelin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000884	0.000912	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.000911	CcSEcCtD
Nafarelin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000865	0.000892	CcSEcCtD
Nafarelin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00086	0.000887	CcSEcCtD
Nafarelin—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000858	0.000885	CcSEcCtD
Nafarelin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000855	0.000882	CcSEcCtD
Nafarelin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000853	0.00088	CcSEcCtD
Nafarelin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000853	0.00088	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000849	0.000876	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000845	0.000872	CcSEcCtD
Nafarelin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000843	0.00087	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000842	0.000869	CcSEcCtD
Nafarelin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000842	0.000869	CcSEcCtD
Nafarelin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000833	0.000859	CcSEcCtD
Nafarelin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000827	0.000853	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000822	0.000848	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000821	0.000848	CcSEcCtD
Nafarelin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00081	0.000836	CcSEcCtD
Nafarelin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000806	0.000832	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.000829	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000796	0.0463	CbGpPWpGaD
Nafarelin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000793	0.000819	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000791	0.000816	CcSEcCtD
Nafarelin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000783	0.000808	CcSEcCtD
Nafarelin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000781	0.000806	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.000805	CcSEcCtD
Nafarelin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00077	0.000795	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000763	0.000787	CcSEcCtD
Nafarelin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000762	0.000787	CcSEcCtD
Nafarelin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000758	0.000782	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000757	0.000782	CcSEcCtD
Nafarelin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000752	0.000777	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000746	0.00077	CcSEcCtD
Nafarelin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.000769	CcSEcCtD
Nafarelin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00074	0.000764	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000739	0.000762	CcSEcCtD
Nafarelin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000727	0.00075	CcSEcCtD
Nafarelin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000726	0.000749	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000748	CcSEcCtD
Nafarelin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00072	0.000743	CcSEcCtD
Nafarelin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000718	0.000741	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000728	CcSEcCtD
Nafarelin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000704	0.000727	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000701	0.000723	CcSEcCtD
Nafarelin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000701	0.000723	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000697	0.00072	CcSEcCtD
Nafarelin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000694	0.000716	CcSEcCtD
Nafarelin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000692	0.000714	CcSEcCtD
Nafarelin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000708	CcSEcCtD
Nafarelin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000708	CcSEcCtD
Nafarelin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000682	0.000704	CcSEcCtD
Nafarelin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000675	0.000697	CcSEcCtD
Nafarelin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000672	0.000694	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.000693	CcSEcCtD
Nafarelin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000667	0.000688	CcSEcCtD
Nafarelin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000665	0.000687	CcSEcCtD
Nafarelin—Rash—Vincristine—peripheral nervous system neoplasm	0.000661	0.000682	CcSEcCtD
Nafarelin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000661	0.000682	CcSEcCtD
Nafarelin—Headache—Vincristine—peripheral nervous system neoplasm	0.000657	0.000678	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000652	0.000673	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.000669	CcSEcCtD
Nafarelin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000647	0.000667	CcSEcCtD
Nafarelin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000655	CcSEcCtD
Nafarelin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000623	0.000643	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000642	CcSEcCtD
Nafarelin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00061	0.000629	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000606	0.0352	CbGpPWpGaD
Nafarelin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000601	0.00062	CcSEcCtD
Nafarelin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000592	0.000611	CcSEcCtD
Nafarelin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000608	CcSEcCtD
Nafarelin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000606	CcSEcCtD
Nafarelin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000603	CcSEcCtD
Nafarelin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000584	0.000603	CcSEcCtD
Nafarelin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000602	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000581	0.0006	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000581	0.0338	CbGpPWpGaD
Nafarelin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000591	CcSEcCtD
Nafarelin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000571	0.00059	CcSEcCtD
Nafarelin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000585	CcSEcCtD
Nafarelin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000562	0.00058	CcSEcCtD
Nafarelin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000551	0.000568	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.000566	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000561	CcSEcCtD
Nafarelin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00054	0.000557	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00054	0.0314	CbGpPWpGaD
Nafarelin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.000557	CcSEcCtD
Nafarelin—Rash—Etoposide—peripheral nervous system neoplasm	0.000536	0.000553	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000535	0.000552	CcSEcCtD
Nafarelin—Headache—Etoposide—peripheral nervous system neoplasm	0.000532	0.000549	CcSEcCtD
Nafarelin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00053	0.000547	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000546	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000541	CcSEcCtD
Nafarelin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000541	CcSEcCtD
Nafarelin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000532	CcSEcCtD
Nafarelin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000522	CcSEcCtD
Nafarelin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000505	0.000521	CcSEcCtD
Nafarelin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000513	CcSEcCtD
Nafarelin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000513	CcSEcCtD
Nafarelin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000513	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000501	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000483	0.0281	CbGpPWpGaD
Nafarelin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000492	CcSEcCtD
Nafarelin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000476	0.000491	CcSEcCtD
Nafarelin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000484	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000483	CcSEcCtD
Nafarelin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000475	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000474	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000474	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000474	CcSEcCtD
Nafarelin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000468	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000455	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000448	CcSEcCtD
Nafarelin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000447	CcSEcCtD
Nafarelin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000445	CcSEcCtD
Nafarelin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000428	0.000441	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.00044	CcSEcCtD
Nafarelin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000438	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000433	CcSEcCtD
Nafarelin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000427	CcSEcCtD
Nafarelin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000407	0.00042	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000414	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000411	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000408	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000405	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000395	CcSEcCtD
Nafarelin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000378	0.00039	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000389	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000358	0.0208	CbGpPWpGaD
Nafarelin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000361	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000343	0.0199	CbGpPWpGaD
Nafarelin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000353	CcSEcCtD
Nafarelin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000348	CcSEcCtD
Nafarelin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000336	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000326	CcSEcCtD
Nafarelin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000325	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000322	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000311	0.0181	CbGpPWpGaD
Nafarelin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000312	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000311	CcSEcCtD
Nafarelin—Rash—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00031	CcSEcCtD
Nafarelin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00031	CcSEcCtD
Nafarelin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000308	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000298	0.0173	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000294	0.0171	CbGpPWpGaD
Nafarelin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000301	CcSEcCtD
Nafarelin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000292	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000289	CcSEcCtD
Nafarelin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000287	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000286	CcSEcCtD
Nafarelin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000285	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000272	0.0158	CbGpPWpGaD
Nafarelin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.00027	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00026	0.0151	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000238	0.0138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000236	0.0137	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000218	0.0126	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000184	0.0107	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000177	0.0103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000176	0.0102	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000154	0.00894	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00014	0.00812	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000139	0.00809	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000135	0.00782	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000129	0.0075	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000129	0.00747	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000122	0.0071	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.65e-05	0.00561	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.5e-05	0.00494	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.26e-05	0.0048	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.87e-05	0.00457	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.22e-05	0.0042	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.11e-05	0.00297	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.02e-05	0.00292	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.97e-05	0.0023	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.74e-05	0.00217	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.63e-05	0.00211	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.6e-05	0.00209	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.3e-05	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.02e-05	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.81e-05	0.00163	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.31e-05	0.00134	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.21e-05	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.95e-05	0.00113	CbGpPWpGaD
